Flavonoid-Protein Binding Processes and their Potential Impact on Human Health

Recent Advances in Polyphenol Research

Volumn 1, Issue , 2008, Pages 67-87

  Dangles, Olivier ^a   Dufour, Claire ^a  

^a UMR A 408 INRA University of Avignon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; HUMAN HEALTH; POTENTIAL IMPACTS; PROTEIN BINDING;

BIOCHEMISTRY;

EID: 84889274382     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444302400.ch3     Document Type: Chapter

References (77)

1. Afman, L. & Muller, M. (2006). Nutrigenomics: from molecular nutrition to prevention of disease. Journal of the American Dietetic Association, 106, 569-576.
2. Ahn, S.C., Kim, G.-Y., Kim, J.-H. et al. (2004). Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells though inhibition of mitogen-activated protein kinases and NF-kB. Biochemical & Biophysical Research Communications, 313, 148-155.
3. Arts, M.J.T.J., Haenen, G.R.M.M., Wilms L.C. et al. (2002). Interactions between flavonoids and proteins: effect on the total antioxidant capacity. Journal of Agricultural & Food Chemistry, 50, 1184-1187.
4. Aura, A.M., O'Leary, K.A., Williamson, G. et al. (2002). Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. Journal of Agricultural & Food Chemistry, 50, 1725-1730.
5. Baxter, N.J., Lilley, T.H., Haslam, E. & Williamson, M.P. (1997). Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in complexation and precipitation. Biochemistry, 36, 5566-5577.
6. Boerboom, A.-M.J.F., Vermeulen, M., van der Woude, H. et al. (2006). Newly constructed stable reporter cell lines for mechanistic studies on electrophile-responsive element-mediated gene expression reveal a role for flavonoid planarity. Biochemical Pharmacology, 72, 217-226.
7. Boulton, D.W., Walle, U.K. & Walle, T. (1998). Extensive binding of the bioflavonoid quercetin to human plasma proteins. Journal of Pharmaceutical Pharmacology, 50, 243-249.
8. Bridges, A.J. (2001). Chemical inhibitors of protein kinases. Chemical Review, 101, 2541-2571.
9. Charlton, A.J., Baxter, N.J., Khan, M.L. et al. (2002). Polyphenol/peptide binding and precipitation. Journal of Agricultural & Food Chemistry, 50, 1593-1601.
10. Chen, J.-C., Ho, F.-M., Chao, P.-D.L. et al. (2005). Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. European Journal of Pharmacology, 521, 9-20.
11. 2-induced apoptosis via antioxidant activity and heme oxygenase 1 gene expression in macrophages. Biochemical Pharmacology, 69, 1839-1851.
12. Ciolino, H.P., Daschner, P.J. & Yeh, G.C. (1999). Dietary flavonoids quercetin and kaempferol are ligands of aryl hydrocarbon receptor that affect CYP1A1 differentially. Biochemical Journal, 340, 715-722.
13. Clifford, M. & Brown, J.E. (2006). Dietary flavonoids and health: broadening the perspective. In: Flavonoids: Chemistry, Biochemistry & Applications (eds O. Andersen & K. Markham), pp. 319-370. CRC Press, Boca Raton, USA.
14. Cos, P., Ying, L., Calomme, M. et al. (1998). Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. Journal of Natural Products, 61, 71-76.
15. Dangles, O. & Dufour, C. (2006). Flavonoid-Protein Interactions. In: Flavonoids: Chemistry, Biochemistry & Applications (eds O. Andersen & K. Markham), pp. 443-469. CRC Press, Boca Raton, USA.
16. Dangles, O., Dufour, C. & Bret, S. (1999). Flavonol-serum albumin complexation. Two-electron oxidation of flavonols and their complexes with serum albumin. Journal of the Chemical Society, Perkin Transactions, 2, 737-744.
17. Day, A.J., Bao, Y., Morgan, M.R.A. & Williamson, G. (2000). Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology & Medicine, 29, 12341243.
18. Day, A.J., Gee, J.M., DuPont M.S., Johnson, I.T. & Williamson, G. (2003). Absorption of quercetin- 3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochemical Pharmacology, 65, 11991206.
19. Deprez, S., Brezillon, C., Rabot, S. et al. (2000). Polymeric proanthocyanidins are catabolized by a human colonic microflora into low molecular weight phenolic acids. Journal of Nutrition, 130, 2733-2738.
20. Doostdar, H., Burke, M.D. & Mayer, R.T. (2000). Bioflavonoids: selective substrates and inhibitors for cytochromes P450 CYP1A and CYP1B1. Toxicology, 144, 31-38.
21. Dufour, C. & Dangles, O. (2005). Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochimica et Biophysica Acta, 1721, 164-173.
22. Dufour, C. & Loonis, M. (2007). Flavonoids and their oxidation products efficiently protect albumin-bound linoleic acid in a model of plasma oxidation. Biochimica et Biophysica Acta, 1770, 958-965.
23. Dufour, C., Loonis, M. & Dangles, O. (2007). Inhibition of the peroxidation of linoleic acid by the flavonoid quercetin within their complex with human serum albumin. Free Radical Biology & Medecine, 43, 241-252.
24. El Hajji, H., Nkhili, E., Tomao, V. & Dangles, O. (2006). Interactions of quercetin with iron and copper ions: complexation and autoxidation. Free Radical Research, 40, 303-320.
25. Galati, G., Moridani, M.Y., Chan, T.S. & O'Brien, P.J. (2001). Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radical Biology & Medicine, 30, 370-382.
26. Galati, G., Sabzevari, O., Wilson, J.X. & O'Brien, P.J. (2002). Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology, 177, 91-104.
27. Gamet-Payrastre, L., Manenti, S., Gratacap, M.-P., Tulliez, J., Chap, H. & Payrastre, B. (1999). Flavonoids and the inhibition of PKC and PI 3-kinase. General Pharmacology, 32, 279-286.
28. Halliwell, B., Rafter, J. & Jenner, A. (2005). Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? American Journal of Clinical Nutrition, 81, 268S-276S.
29. Halliwell, B., Zhao, K. & Whiteman, M. (2000). The gastrointestinal tract: a major site of antioxidant action? Free Radical Research, 33, 819-830.
30. Harborne, J.B. & Williams, C.A. (2000). Advances in flavonoid research since 1992. Phytochemistry, 55, 481-504.
31. Havsteen, B.H. (2002). The biochemistry and medical significance of the flavonoids. Pharmacology & Therapeutics, 96, 67-202.
32. Hodek, P., Trefil, P. & Stiborova, M. (2002). Flavonoids: potent and versatile biologically active compounds interacting with cytochromes P450. Chemico-Biological Interactions, 139, 1-21.
33. Hollman, P.C.H. & Katan, M.B. (1999). Dietary flavonoids: intake, health effects and bioavailability. Food Chemical Toxicology, 37, 937-942.
34. Ishige, K., Schubert, D. & Sagara, Y. (2001). Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biology & Medicine, 30, 433-446.
35. Jobstl, E., Howse, J.R., Fairclough, J.P.A. & Williamson, M.P. (2006). Noncovalent cross-linking of casein by epigallocatechin gallate characterized by single molecule force microscopy. Journal of Agricultural & Food Chemistry, 54, 4077-4081.
36. Jung, U.J., Lee, M.-K., Park, Y.B., Kang, M.A. & Choi, M.-S. (2006). Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. International Journal of Biochemistry & Cell Biology, 38, 1134-1145.
37. Kaldas, M.I., Walle, U.K., van der Woude, H., McMillan, J.M. & Walle, T. (2005). Covalent binding of the flavonoid quercetin to human serum albumin. Journal of Agricultural & Food Chemistry, 53, 4194-4197.
38. Kang, Z.C., Tsai, S.J. & Lee, H. (1999). Quercetin inhibits benzo[a]pyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 expression. Nutrition & Cancer, 35, 175-179.
39. Kanner, J. & Lapidot, T. (2001). The stomach as a bioreactor: dietary lipid peroxidation in the gastric fluid and the effects of plant-derived antioxidants. Free Radical Biology & Medicine, 31, 1388-1395.
40. Kim, S.H., Shin, K.-J., Kim, D. et al. (2003). Luteolin inhibits the nuclear factor-KB transcriptional activity in Rat-1 fibroblasts. Biochemical Pharmacology, 66, 955-963.
41. Komoto, J., Yamada, T., Watanabe, K., Takusagawa, F. (2004). Crystal structure of human prostaglandin F synthase. Biochemistry, 43, 2188-2198.
42. Kostelac, D., Rechkemmer, G. & Briviba, K. (2003). Phytoestrogens modulate binding response of estrogen receptors a and ß to the estrogen response element. Journal of Agricultural & Food Chemistry, 51, 7632-7635.
43. Kuiper, G.G.J.M., Lemmen, J.G., Carlson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., van der Burg, B. & Gustafsson, J.-A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ß. Endocrinology, 139, 4252-4263.
44. Liang, Y.C., Tsai, S.-H., Tsai, D.-C., Lin-Shiau, S.-Y. & Lin, J.-K. (2001). Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-y by flavonoids in mouse macrophages. FEBS Letters, 496, 12-18.
45. Lin, C.-M., Chen, C.-S., Chen, C.-T., Liang, Y.-C. & Lin, J.-K. (2002). Molecular modeling of flavonoids that inhibit xanthine oxidase. Biochemical & Biophysical Research Communications, 294, 167-172.
46. Maliar, T., Jedinak, A., Kadrabova, J. & Sturdik, E. (2004). Structural aspects of flavonoids as trypsin inhibitors. European Journal of Medicinal Chemistry, 39, 241-248.
47. Manach, C., Morand, C., Crespy, V. et al. (1998). Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters, 426, 331-336.
48. Moro, S., van Rhee, A.M., Sanders, L.H. & Jacobson, K.A. (1998). Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model. Journal of Medicinal Chemistry, 41, 46-52.
49. Moskaug, J.O., Carlsen, H., Myhrstad, M. & Blomhoff, R. (2004). Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mechanisms of Ageing & Development, 125, 315-324.
50. Myhrstad, M.C.W., Carlsen, H., Nordstrom, O., Blomhoff, R. & Moskaug, J.O. (2002). Flavonoids increase the intracellular glutathione level by transactivation of the y-glutamylcysteine synthetase catalytical subunit promoter. Free Radical Biology & Medicine, 32, 386-393.
51. Ohno, Y., Naganuma, T., Ogawa, T. & Muramoto, K. (2006). Effect of lectins on the transport of food factors in caco-2 cell monolayers. Journal of Agricultural & Food Chemistry, 54, 548-553.
52. O'Leary, K.A., Day, A.J., Needs, P.W., Mellon, F.A., O'Brien N.M. & Williamson, G. (2003). Metabolism of quercetin-7- and quercetin-3-glucuronides in an in vitro hepatic model: the role of human ß-glucuronidase, sulfotransferase, catechol O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochemical Pharmacology, 65, 479-491.
53. Passamonti, S., Vrhovsek, U. & Mattivi, F. (2002). The interaction of anthocyanins with bilitranslocase. Biochemical & Biophysical Research Communications, 296, 631-636.
54. Pietta, P.G. (2000). Flavonoids as antioxidants. Journal of Natural Products, 63, 1035-1042.
55. Richard-Forget, F., Gauillard, F., Hugues, M., Thiry, J.-M., Boivin, P. & Nicolas, J. (1995). Inhibition of horse bean and germinated barley lipoxygenases by some phenolic compounds. Journal of Food Science, 60, 1325-1329.
56. Sadik, C.D., Sies, H. & Schewe, T. (2003). Inhibition of 15-lipoxygenases by flavonoids: structure- activity relations and mode of action. Biochemical Pharmacology, 65, 773-781.
57. Scalbert, A. & Williamson, G. (2000). Dietary intake and bioavailability of polyphenols. Journal of Nutrition, 130, 2073S-2085S.
58. Schroeter, H., Boyd, C., Spencer, J.P.E., Williams, R.J., Cadenas, E. & Rice-Evans, C. (2002). MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiology of Aging, 23, 861-880.
59. Schroeter, H., Spencer, J.P.E., Rice-Evans, C. & Williams, R.J. (2001). Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochemical Journal, 358, 547-557.
60. Siebert, K.J. (1999). Effects of protein-polyphenol interactions on beverage haze, stabilization, and analysis. Journal of Agricultural & Food Chemistry, 47, 353-362.
61. Silva, I.D., Rodrigues, A.S., Gaspar, J., Maia, R., Laires, A. & Rueff, J. (1997). Involvement of rat cytochrome 1A1 in the biotransformation of kaempferol to quercetin: relevance to the genotox- icity of kaempferol. Mutagenesis, 12, 383-390.
62. Spencer, J.P.E., El Mohsen, M.M.A. & Rice-Evans, C. (2004). Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Archives of Biochemistry & Biophysics, 423, 148-161.
63. Talalay, P., Dinkova-Kostova, A.T. & Holtzclaw, W.D. (2003). Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Advances in Enzyme Regulation, 43, 121-134.
64. Talavera, S., Felgines, C., Texier, O., Besson, C., Lamaison, J.-L. & Remesy, C. (2003). Anthocyanins are efficiently absorbed from the stomach of anesthetized rats. Journal of Nutrition, 133, 41784182.
65. van Acker, S.A.B.E., van Balen, G.P., van den Berg, D.J., Bast, A. & van der Vijgh, W.J.F. (1998). Influence of iron chelation on the antioxidant activity of flavonoids. Biochemical Pharmacology, 56, 935-943.
66. van Acker, S.A.B.E, van den Berg, D.J., Tromp, M.N.J.L., Griffioen, D.H., van der Vijgh, W.J.F. & Bast, A. (1996). Structural aspects of antioxidant activity of flavonoids. Free Radical Biology & Medicine, 20, 331-342.
67. van Zanden, J.J., Ben Amman, O., van Iersel, M.L.P.S. et al. (2003). Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin. Chemico-Biological Interactions, 145, 139-148.
68. Vulcain, E., Goupy, P., Caris-Veyrat, C. & Dangles, O. (2005). Inhibition of the metmyoglobin- induced peroxidation of linoleic acid by dietary antioxydants: action in the aqueous phase vs. lipid phase. Free Radical Research, 35, 547-563.
69. Walle, T. (2004). Absorption and metabolism of flavonoids. Free Radical Biology & Medicine, 36, 829-837.
70. Walle, T., Browning, A.M., Steed, L.L., Reed, S.G. & Walle, U.K. (2005). Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. Journal of Nutrition, 135, 48-52.
71. Walle, T., Vincent, T.S. & Walle, U.K. (2003). Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochemical Pharmacology, 65, 1603-1610.
72. Williams, R.J., Spencer, J.P.E. & Rice-Evans, C. (2004). Flavonoids: antioxidants or signalling molecules. Free Radical Biology & Medicine, 36, 838-849.
73. Wroblewski, K., Muhandiram, R., Chakrabartty, A. & Bennick, A. (2001). The molecular interactions of human salivary histatins with polyphenolic compounds. European Journal of Biochemistry, 268, 4384-4397.
74. Yang, E.B., Zhang, K., Cheng, L.Y. & Mack, P. (1998). Butein, a specific protein tyrosine kinase inhibitor. Biochemical & Biophysical Research Communications, 245, 435-438.
75. Yoshizumi, M., Tsuchiya, K., Suzaki, Y. et al. (2002). Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical & Biophysical Research Communications, 293, 1458-1465.
76. Zhai, S., Dai, R., Friedman, F.K. & Vestal, R.E. (1998). Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metabolism & Disposition, 26, 989-992.
77. Zsila, F., Bikádi, Z. & Simonyi, M. (2003). Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods. Biochemical Pharmacology, 65, 447-456.